-
Subject Areas on Research
-
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.
-
A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly.
-
A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.
-
Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation.
-
Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma.
-
An acoustofluidic trap and transfer approach for organizing a high density single cell array.
-
Analysis of wntless (WLS) expression in gastric, ovarian, and breast cancers reveals a strong association with HER2 overexpression.
-
Association between cytosolic expression of BRCA1 and metastatic risk in breast cancer.
-
CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers.
-
Cadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumour.
-
Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.
-
Comparison of Human Tissue Microarray to Human Pericyte Transcriptome Yields Novel Perivascular Cell Markers.
-
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.
-
DEK expression in Merkel cell carcinoma and small cell carcinoma.
-
Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape.
-
Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
-
EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation.
-
ERCC1 protein expression is associated with differential survival in oropharyngeal head and neck squamous cell carcinoma.
-
Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions.
-
Evaluation of an epithelial plasticity biomarker panel in men with localized prostate cancer.
-
Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression.
-
FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival.
-
FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate.
-
Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression.
-
Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation.
-
Graphite-coated magnetic nanoparticle microarray for few-cells enrichment and detection.
-
Heat shock protein 70-binding protein 1 is highly expressed in high-grade gliomas, interacts with multiple heat shock protein 70 family members, and specifically binds brain tumor cell surfaces.
-
Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease.
-
High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma.
-
High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma.
-
Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p.
-
Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
-
Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer.
-
Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis.
-
Interpathologist Diagnostic Agreement for Non-Small Cell Lung Carcinomas Using Current and Recent Classifications.
-
Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.
-
Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
-
Ki-67 Expression in Breast Cancer Tissue Microarrays: Assessing Tumor Heterogeneity, Concordance With Full Section, and Scoring Methods.
-
Laminin alpha 2 enables glioblastoma stem cell growth.
-
Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma.
-
Making a Tissue Microarray.
-
Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma.
-
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.
-
Molecular characterization of the tumor-suppressive function of nischarin in breast cancer.
-
Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
-
Nuclear Snail1 and nuclear ZEB1 protein expression in invasive and intraductal human breast carcinomas.
-
Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas.
-
Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma.
-
PD-L1 Expression Correlates With Young Age and CD8+ TIL Density in Poorly Differentiated Cervical Squamous Cell Carcinoma.
-
Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium.
-
Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2α.
-
Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial.
-
Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy.
-
Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases.
-
Reactivation of p53 by a Cytoskeletal Sensor to Control the Balance Between DNA Damage and Tumor Dissemination.
-
Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcoma.
-
Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.
-
Snail promotes resistance to enzalutamide through regulation of androgen receptor activity in prostate cancer.
-
Syndecan-1 facilitates breast cancer metastasis to the brain.
-
The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma.
-
The expression of PTEN is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy.
-
The oncogenic gene fusion TMPRSS2: ERG is not a diagnostic or prognostic marker for ovarian cancer.
-
Thrombin expression in prostate: a novel finding.
-
Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer.
-
Uncertainty in the utility of immunohistochemistry in mismatch repair protein expression in epithelial ovarian cancer.
-
Use of tissue microarray and automated quantitative analysis for screening and validation of potential biomarkers in mantle cell lymphoma.
-
miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy.
-
p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function.
-
Keywords of People